Professor Simon Heller provides guidance to initiating basal insulin and managing hypoglycaemia.Learning objective: Following this activity you will be able to confidently initiate basal insulin

3. Sulphonylureas and managing hypoglycaemia in practice

Nov 26th, 2020 9m 53s

P Professor Chan discusses SU-related hypoglycaemia and provides practical advice for its management.Learning objective: Following this activity, you will be able to better reduce risk of SU-induced hypoglycaemia and support patients in managin

2. How to support people earlier in living with diabetes

Nov 26th, 2020 9m 12s

Professor Michael Vallis and Joe Dias discuss how to identify and use teachable moments to help people with diabetes achieve glycaemic control earlier.Learning objective: Following this activity, you will be more confident in motivating patient

4. Why should I treat more intensively earlier?

Nov 26th, 2020 6m 12s

Professor Knop outlines why treating early and intensifying treatment as appropriate is likely to reduce diabetes-related complications. Learning objectives: Following this activity, you will be able to better discuss the link between loss of b

6. The key role of primary care in type 2 diabetes

Nov 25th, 2020 5m 30s

Professor Xavier Cos discusses why primary care physicians are so important in diabetes management.Learning objectives: Following this activity, you will be more confident in tailoring treatment and developing a plan for all patients in your cl

5. Can GLP-1 receptor agonists and SGLT-2 inhibitors be used together?

Nov 25th, 2020 8m 56s

Professor Knop provides advice on using these agents in combination – who would benefit most, managing potential side effects and considerations for use.Learning objectives: Following this activity, you will be able to: Confidently identify pe

7. An exciting time ahead for primary care physicians in diabetes

Nov 25th, 2020 3m 56s

Professor Kamlesh Khunti discusses what the key characteristics of therapeutic agents available in diabetes are.Learning objective: Following this activity, you will be able to adopt an approach to treatment that considers all available options

11. Improving quality of life and confidence with continuous glucose monitoring

Nov 25th, 2020 5m 40s

Mr Joe Dias discusses how continuous glucose monitoring can transform lives.Learning objective: Following this activity, you will be more confidently discuss the benefits of continuous glucose monitoring with people with diabetes.

10. Which people with type 2 diabetes would benefit from SGLT-2 inhibitors and GLP-1 receptor agonists?

Nov 25th, 2020 11m 4s

Listen to Professor Liebl outline when and how he uses these modern agents.Learning objective: Following this activity, you will be able to confidently identify individuals in whom SGLT-2 inhibitors and GLP-1 receptor agonists are likely to be

9. How I have changed my practice following new guidelines

Nov 25th, 2020 8m 22s

Clinical practice in type 2 diabetes has changed, learn more from Professor Abrahamson.Learning objective: Following this activity, you will be able to more confidently tailor treatments for people with T2DM, particularly newer agents

8. Discussing injectables with people living with diabetes

Nov 25th, 2020 8m 43s

Professor Liebl discusses best communication approaches for insulins and GLP-1 RAs. Learning objective: Following this activity, you will be able to better overcome the barriers to initiating injectables and discuss the differences between insu

Rate